Literature DB >> 33505228

Prediction of Histologic Subtype and FNCLCC Grade by SUVmax Measured on 18F-FDG PET/CT in Patients with Retroperitoneal Liposarcoma.

Cheng-Peng Li1, Dao-Ning Liu1, Ni-Na Zhou2, Xiu-Yun Tian1, Zhen Wang1, Bo-Nan Liu1, Chun-Yi Hao1.   

Abstract

This study aimed to evaluate the usefulness of maximum standardized uptake value (SUVmax) on 18F-fluorodeoxyglucose positron emission tomography with computed tomography (18F-FDG PET/CT) in differentiating the subtypes and tumor grades of retroperitoneal liposarcoma (RPLS). The data of RPLS patients who underwent surgical resection from November 2013 to December 2019 at the sarcoma center of our institute were reviewed. The demographics, clinical features, and SUVmax of 84 patients who underwent preoperative 18F-FDG PET/CT scans were analyzed. Of these, 19 patients (22.6%) were with well-differentiated liposarcoma (WDLPS), 60 patients (71.4%) were with dedifferentiated liposarcoma (DDLPS), and 5 patients (6.0%) were with pleomorphic liposarcoma (PMLPS). The median SUVmax of WDLPS, DDLPS, and PMLPS groups was 2.8 (IQR: 1.9-3.2), 6.2 (IQR: 4.1-11.3), and 4.5 (IQR: 4.0-7.4). The ROC curve suggested 3.8 as an approximate cutoff value of SUVmax for distinguishing WDLPS and non-WDLPS (sensitivity = 0.769; specificity = 0.895). The median SUVmax for FNCLCC Grades 1, 2, and 3 of RPLS was 2.5 (IQR: 1.9-3.2), 4.5 (IQR: 3.2-6.7), and 9.0 (IQR: 6.0-13.3). The ROC curves suggest that SUVmax of ≤3.8 and >5.3 can be used for predicting FNCLCC Grades 1 and 3, respectively. The result showed that 18F-FDG PET/CT exhibited high sensitivity and specificity for identifying the subtypes and FNCLCC grades of RPLS. Additionally, 18F-FDG PET/CT might be a useful complementary imaging modality for guiding suitable biopsy location of RPLS.
Copyright © 2021 Cheng-Peng Li et al.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33505228      PMCID: PMC7806371          DOI: 10.1155/2021/7191363

Source DB:  PubMed          Journal:  Contrast Media Mol Imaging        ISSN: 1555-4309            Impact factor:   3.161


  23 in total

Review 1.  Utility of positron emission tomography/computed tomography (PET/CT) imaging in the evaluation of sarcomas: A systematic review.

Authors:  Hui Jun Lim; Chin-Ann Johnny Ong; Joey Wee-Shan Tan; Melissa Ching Ching Teo
Journal:  Crit Rev Oncol Hematol       Date:  2019-07-21       Impact factor: 6.312

2.  Total lesion glycolysis by 18F-FDG PET/CT is a reliable predictor of prognosis in soft-tissue sarcoma.

Authors:  Eun-Seok Choi; Seung-Gyun Ha; Han-Soo Kim; Jae Hong Ha; Jin Chul Paeng; Ilkyu Han
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-07-24       Impact factor: 9.236

Review 3.  Grading of soft tissue sarcomas: review and update.

Authors:  Jean-Michel Coindre
Journal:  Arch Pathol Lab Med       Date:  2006-10       Impact factor: 5.534

4.  Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma.

Authors:  Marcus C B Tan; Murray F Brennan; Deborah Kuk; Narasimhan P Agaram; Cristina R Antonescu; Li-Xuan Qin; Nicole Moraco; Aimee M Crago; Samuel Singer
Journal:  Ann Surg       Date:  2016-03       Impact factor: 12.969

5.  Intense accumulation of 18F-FDG, not enhancement on MRI, helps to guide the surgical biopsy accurately in soft tissue tumors.

Authors:  Jong Hoon Park; Eun Kyung Park; Chang Ho Kang; Chul Hwan Kim; Jae Gol Choe; Won Noh
Journal:  Ann Nucl Med       Date:  2009-10-28       Impact factor: 2.668

6.  The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors.

Authors:  Duk-Seop Shin; Oog-Jin Shon; Dong-Sung Han; Joon-Hyuk Choi; Kyung-Ah Chun; Ihn-Ho Cho
Journal:  Ann Nucl Med       Date:  2008-08-29       Impact factor: 2.668

7.  CT and MR imaging of abdominal liposarcoma.

Authors:  T Kim; T Murakami; H Oi; K Tsuda; M Matsushita; K Tomoda; H Fukuda; H Nakamura
Journal:  AJR Am J Roentgenol       Date:  1996-04       Impact factor: 3.959

8.  Use of 18F-FDG-PET/CT for Retroperitoneal/Intra-Abdominal Soft Tissue Sarcomas.

Authors:  Dao-Ning Liu; Zhong-Wu Li; Hai-Yue Wang; Min Zhao; Wei Zhao; Chun-Yi Hao
Journal:  Contrast Media Mol Imaging       Date:  2018-07-02       Impact factor: 3.161

9.  Incidence, distribution of histological subtypes and primary sites of soft tissue sarcoma in China.

Authors:  Zhixun Yang; Rongshou Zheng; Siwei Zhang; Hongmei Zeng; He Li; Wanqing Chen
Journal:  Cancer Biol Med       Date:  2019-08       Impact factor: 4.248

10.  PET/CT Imaging as a Diagnostic Tool in Distinguishing Well-Differentiated versus Dedifferentiated Liposarcoma.

Authors:  Amanda Parkes; Elizabeth Urquiola; Priya Bhosale; Heather Lin; Kelsey Watson; Wei-Lien Wang; Barry Feig; Keila Torres; Christina L Roland; Anthony P Conley; Maria Zarzour; J Andrew Livingston; Ravin Ratan; Joseph Ludwig; Dejka M Araujo; Vinod Ravi; Robert S Benjamin; Shreyaskumar Patel; Neeta Somaiah
Journal:  Sarcoma       Date:  2020-05-29
View more
  3 in total

Review 1.  Management of Locally Recurrent Retroperitoneal Sarcoma in the Adult: An Updated Consensus Approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group.

Authors:  William W Tseng; Carol J Swallow; Dirk C Strauss; Sylvie Bonvalot; Piotr Rutkowski; Samuel J Ford; Ricardo J Gonzalez; Rebecca A Gladdy; David E Gyorki; Mark Fairweather; Kyo Won Lee; Markus Albertsmeier; Winan J van Houdt; Magalie Fau; Carolyn Nessim; Giovanni Grignani; Kenneth Cardona; Vittorio Quagliuolo; Valerie Grignol; Jeffrey M Farma; Elisabetta Pennacchioli; Marco Fiore; Andrew Hayes; Dimitri Tzanis; Jacek Skoczylas; Max L Almond; John E Mullinax; Wendy Johnston; Hayden Snow; Rick L Haas; Dario Callegaro; Myles J Smith; Toufik Bouhadiba; Anant Desai; Rachel Voss; Roberta Sanfilippo; Robin L Jones; Elizabeth H Baldini; Andrew J Wagner; Charles N Catton; Silvia Stacchiotti; Khin Thway; Christina L Roland; Chandrajit P Raut; Alessandro Gronchi
Journal:  Ann Surg Oncol       Date:  2022-06-29       Impact factor: 4.339

2.  Development and Validation of a Prognostic Model to Predict the Prognosis of Patients With Retroperitoneal Liposarcoma: A Large International Population-Based Cohort Study.

Authors:  Yiding Li; Guiling Wu; Yujie Zhang; Wanli Yang; Xiaoqian Wang; Lili Duan; Liaoran Niu; Junfeng Chen; Wei Zhou; Jinqiang Liu; Helun Zhong; Daiming Fan; Liu Hong
Journal:  Front Oncol       Date:  2022-06-02       Impact factor: 5.738

3.  Hamartochondroma Pleural Lesion Mimicking Liposarcoma: A Case Report.

Authors:  Gabrielle Drevet; Erik Kovacs; Lara Chalabreysse; Delphine Gamondes; François Tronc
Journal:  Curr Oncol       Date:  2022-05-11       Impact factor: 3.109

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.